Can the New Shingles Vaccine Attract More Takers?The availability of a better shingles vaccine may attract more people to be vaccinated.
What Triggers Shingles?What causes the dormant Varicella zoster virus to erupt as shingles?
GSK Launches More Effective Shingles Vaccine
GSK Launches More Effective Shingles VaccineWill Shingrix become the new go-to shingles vaccine?
Shingles vaccine wins approvalFDA approved the herpes zoster vaccine (Shingrix, GlaxoSmithKline) to treat shingles in adults aged 50 years and older.
Shingles associated with increased risk of stroke, heart attackPatients who have a history of herpes zoster may have an increased risk of heart attack or stroke, according to findings published in a research letter.
Don't overlook vaccines in value-based benefit designA new study highlights why vaccination costs should be a top consideration when evaluating benefit offerings.
Autoimmune disease + shingles = 50% increase in stroke riskPeople who have autoimmune diseases, including psoriasis, who get incident herpes zoster have a 50 percent increased stroke risk within a month of developing shingles, according to a new study.
Topical gel combo decreases severe pruritus, pain in shingles-related caseStudy details how a topical gel helped bring “significant relief” to patient’s severe pain and itching. Find out how
Study: Little difference in shingles risk among RA biologicsResults of a new study suggest that no matter what biologic they are treated with, older patients with rheumatoid arthritis face pretty much the same risk of developing herpes zoster.
Zoster vaccine effective in older chemotherapy patientsHerpes zoster vaccine continues to be effective in protecting older adults against shingles, even after they undergo chemotherapy, a study published August 4 in Clinical Infectious Diseases.